De Ke Jiang

Summary

Affiliation: Fudan University
Country: China

Publications

  1. ncbi TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis
    De Ke Jiang
    The State Key Laboratory of Genetic Engineering, Fudan University, 200433, Shanghai, China
    Med Oncol 28:1129-35. 2011
  2. ncbi TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis
    De Ke Jiang
    The State Key Laboratory of Genetic Engineering, Fudan University, Shanghai 200433, China
    World J Gastroenterol 17:1227-33. 2011
  3. ncbi TP53 Arg72Pro polymorphism and skin cancer risk: a meta-analysis
    De Ke Jiang
    The State Key Laboratory of Genetic Engineering, Shanghai, China
    J Invest Dermatol 131:220-8. 2011
  4. ncbi Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk
    De Ke Jiang
    State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China
    Urology 76:765.e1-7. 2010
  5. ncbi Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk
    Su Qin Shen
    State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, 200433, China
    Mol Biol Rep 39:4683-90. 2012
  6. ncbi Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma
    De Ke Jiang
    State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China
    Nat Genet 45:72-5. 2013
  7. ncbi MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis
    Guo yuan Liu
    The State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China
    Arch Med Res 42:149-55. 2011
  8. ncbi Characterization and expression of HLysG2, a basic goose-type lysozyme from the human eye and testis
    Peng Huang
    State Key Laboratory of Genetic Engineering, Fudan University, Shanghai 200433, China
    Mol Immunol 48:524-31. 2011

Detail Information

Publications8

  1. ncbi TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis
    De Ke Jiang
    The State Key Laboratory of Genetic Engineering, Fudan University, 200433, Shanghai, China
    Med Oncol 28:1129-35. 2011
    ..The reported significant association between this polymorphism and endometrial cancer risk may be due to methodological errors such as selection bias, small sample size, Type I error, and population stratification...
  2. ncbi TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis
    De Ke Jiang
    The State Key Laboratory of Genetic Engineering, Fudan University, Shanghai 200433, China
    World J Gastroenterol 17:1227-33. 2011
    ..To investigate the association between TP53 Arg72Pro polymorphism and esophageal cancer (EC) risk using meta-analysis...
  3. ncbi TP53 Arg72Pro polymorphism and skin cancer risk: a meta-analysis
    De Ke Jiang
    The State Key Laboratory of Genetic Engineering, Shanghai, China
    J Invest Dermatol 131:220-8. 2011
    ..In conclusion, this meta-analysis suggests that the TP53 Arg72Pro polymorphism may have little involvement in skin cancer susceptibility...
  4. ncbi Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk
    De Ke Jiang
    State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China
    Urology 76:765.e1-7. 2010
    ..Studies investigating the association between TP53 Arg72Pro polymorphism and bladder cancer risk have reported conflicting results...
  5. ncbi Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk
    Su Qin Shen
    State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, 200433, China
    Mol Biol Rep 39:4683-90. 2012
    ..In conclusion, this meta-analysis suggests that the Arg allele is at a moderately reduced risk for ovarian cancer and this polymorphism might protect against ovarian carcinogenesis...
  6. ncbi Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma
    De Ke Jiang
    State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China
    Nat Genet 45:72-5. 2013
    ..0008 and 0.0002, respectively). We also found significantly lower mRNA expression of STAT4 in HCC tumor tissues compared with paired adjacent nontumor tissues (P = 2.33 × 10(-14))...
  7. ncbi MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis
    Guo yuan Liu
    The State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China
    Arch Med Res 42:149-55. 2011
    ..Studies investigating the association between the polymorphism and human hepatocellular carcinoma (HCC) risk reported conflicting results. We performed a meta-analysis to explore the association of this polymorphism and HCC risk...
  8. ncbi Characterization and expression of HLysG2, a basic goose-type lysozyme from the human eye and testis
    Peng Huang
    State Key Laboratory of Genetic Engineering, Fudan University, Shanghai 200433, China
    Mol Immunol 48:524-31. 2011
    ..Results indicated that HLysG2 is a potent antibacterial protein that may play a role in the innate immunity of the human eye...